Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

<< Previous

Bullboard Posts

Next >>

Post by hcdtradingon Jul 13, 2021 2:07pm

211 Views

Post# 33536542

Almost 15 years SBM has been around

Management are sociopaths if they are not embarrassed at the progress or lack there of.

We are in the summer months and they are typically not good for TSXV stocks but still no excuses for this one.

The only thing that kinda interested me was the anti aging space because that is where the massive potential is but they are too all over the place with everthing they are doing.

What happened to the Cousteau brothers? haha

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing